Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024


ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three months and year ended December 31, 2023 on Thursday, March 28, 2024 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast beginning at 4:30 p.m. Eastern time to discuss the results, provide an update on recent corporate developments and answer questions.

Participants are encouraged to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the start of the call. Those unable to pre-register may participate by dialing (844) 868-8846 (U.S.) or (412) 317-5465 (International). A webcast of the call can also be accessed at ENDRA's Investor Relations page and here.

A telephone replay will be available until April 4, 2024 by dialing (877) 344-7529 (U.S.) or (412) 317-0088 (International) and providing the passcode 8041087. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.

About ENDRA Life Sciences Inc.

ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS® is designed to work in concert with the more than 700,000 ultrasound systems in use globally today. TAEUS® is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD) (formerly known as NAFLD-NASH), a chronic liver spectrum that affects over two billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS®, including visualization of tissue temperature during energy-based surgical procedures. For more information, please visit www.endrainc.com.


These press releases may also interest you

at 08:18
The following issues have been halted by CIRO: Company: Cathedral Energy Services Ltd. TSX Symbol: CET All Issues: Yes Reason: Dissemination Halt Time (ET): 8:07 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a...

at 08:15
Baylin Technologies Inc. (the "Company") is pleased to announce that its Galtronics subsidiary has received a multi-year, multi-million dollar award for a 4G/5G mobile antenna solution....

at 08:15
Private sector employment increased by 150,000 jobs in June and annual pay was up 4.9 percent year-over-year, according to the June ADP® National Employment Reporttm produced by the ADP Research Institute® in collaboration with the Stanford Digital...

at 08:10
Ameresco, Inc. , a leading cleantech integrator specializing in energy efficiency and renewable energy, today announced that it will release its second quarter 2024 financial results after the close of the market on Monday, August 5, 2024. The...

at 08:05
COPT Defense Properties ("COPT Defense" or the "Company") announces the release date and conference call details in which management will discuss second quarter 2024 results. Details: Results Release Date: Monday, July 29, 2024 after...

at 08:05
Carvana Co. , the leading e-commerce platform for buying and selling used cars, today announced it will report its second quarter 2024 financial results for the period ended June 30, 2024, after the market closes on Wednesday, July 31, 2024. On that...



News published on and distributed by: